“…Another controlled human clinical trial revealed that B. coagulans MTCC 5856 has demonstrated significant efficacy in patients with diarrhea‐predominant IBS in mitigating their clinical symptoms at a dose of 2 × 10 9 spore/day when supplemented for 90 days (Majeed, Nagabhushanam, Natarajan, Sivakumar, Ali, et al., ). Further, B. coagulans MTCC 5856 was found to be highly stable during processing and storage of various functional foods due to its spore nature (Majeed, Majeed, et al., ) and also phenotypically and genotypically consistent over multiple years of commercial production (Majeed, Nagabhushanam, Natarajan, Sivakumar, Eshuis‐de Ruiter, et al., ).…”